These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 1765894

  • 1. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI, Gaudino JA, Hanson CV.
    J Psychoactive Drugs; 1991; 23(2):225-32. PubMed ID: 1765894
    [Abstract] [Full Text] [Related]

  • 2. The clinical significance of HTLV-I and HTLV-II infection in the AIDS epidemic.
    Pierik LT, Murphy EL.
    AIDS Clin Rev; 1991; ():39-57. PubMed ID: 1868010
    [Abstract] [Full Text] [Related]

  • 3. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, Jiménez V, Silva T, Project Itínere Working Group.
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [Abstract] [Full Text] [Related]

  • 4. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil.
    Barcellos NT, Fuchs SC, Mondini LG, Murphy EL.
    Sex Transm Dis; 2006 May; 33(5):302-6. PubMed ID: 16505751
    [Abstract] [Full Text] [Related]

  • 5. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C, Pilotti E, Bertazzoni U.
    AIDS Rev; 2007 May; 9(3):140-9. PubMed ID: 17982939
    [Abstract] [Full Text] [Related]

  • 6. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
    Jõgeda EL, Avi R, Pauskar M, Kallas E, Karki T, Des Jarlais D, Uusküla A, Lutsar I, Huik K.
    Infect Genet Evol; 2016 Sep; 43():83-5. PubMed ID: 27223634
    [Abstract] [Full Text] [Related]

  • 7. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
    Lefrère F, Wattel E, Mariotti M, Agis F, Gordien E, Lefrère JJ.
    J Infect Dis; 1992 Jul; 166(1):212-3. PubMed ID: 1607702
    [No Abstract] [Full Text] [Related]

  • 8. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA, Zucker-Franklin D, Marmor M, Legler PM.
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [Abstract] [Full Text] [Related]

  • 9. The epidemiology and disease outcomes of human T-lymphotropic virus type II.
    Roucoux DF, Murphy EL.
    AIDS Rev; 2004 Nov; 6(3):144-54. PubMed ID: 15595431
    [Abstract] [Full Text] [Related]

  • 10. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL, Saguier MC, Salamone HJ, Carreras LA.
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [Abstract] [Full Text] [Related]

  • 11. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF, Lewandowski CA, Belian BT, Burczak J, Markowitz N, Lee H, Saravolatz LD.
    Henry Ford Hosp Med J; 1992 Dec; 40(1-2):131-5. PubMed ID: 1428966
    [Abstract] [Full Text] [Related]

  • 12. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S.
    J Infect Dev Ctries; 2013 Jun 15; 7(6):453-67. PubMed ID: 23771289
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS, Chu A, Allain JP, Lee H, Cerney M, Nemoto T.
    N Y State J Med; 1991 Mar 15; 91(3):93-7. PubMed ID: 2047026
    [Abstract] [Full Text] [Related]

  • 16. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
    Brites C, Sampalo J, Oliveira A.
    AIDS Rev; 2009 Mar 15; 11(1):8-16. PubMed ID: 19290030
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile.
    Barrientos A, Lopez M, Sotomayor C, Pilleux L, Calderón S, Navarrete M, Otth C.
    J Med Virol; 2011 Apr 15; 83(4):745-8. PubMed ID: 21328393
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.
    Broutet N, de Queiroz Sousa A, Basilio FP, Sá HL, Simon F, Dabis F.
    Int J STD AIDS; 1996 Apr 15; 7(5):365-9. PubMed ID: 8894828
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases.
    Giuliani M, Rezza G, Lepri AC, Di Carlo A, Maini A, Crescimbeni E, Palamara G, Prignano G, Caprilli F.
    Sex Transm Dis; 2000 Feb 15; 27(2):87-92. PubMed ID: 10676975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.